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DObjectives: Precursor events are undesirable events that can lead to a subsequent adverse event and have been
associated with postoperative mortality. The purpose of the present study was to determine whether precursor
events are associated with a composite endpoint of major adverse cardiac events (MACE) (death, acute renal
failure, stroke, infection) in a low- to medium-risk coronary artery bypass grafting, valve, and valve plus coro-
nary artery bypass grafting population. These events might be targets for strategies aimed at quality improve-
ment.
Methods: The present study was a retrospective cohort design performed at the Queen Elizabeth Health Science
Centre. Low- to medium-risk patients who had experienced postoperative MACE were matched 1:1 with
patients who had not experienced postoperative MACE. The operative notes, for both groups, were scored by
5 surgeons to determine the frequency of 4 precursor events: bleeding, difficulty weaning from cardiopulmonary
bypass, repair or regrafting, and incomplete revascularization or repair. A univariate comparison of1 precursor
events in the matched groups was performed.
Results:A total of 311 MACE patients (98.4%) were matched. The primary outcome occurred more frequently
in the MACE group than in the non-MACE group (33% vs 24%; P ¼ .015). The incidence of the individual
events of bleeding and difficulty weaning from cardiopulmonary bypass was significantly higher in the
MACE group. Those patients with a precursor event in the absence of MACE also appeared to have a greater
prevalence of other important postoperative outcomes.
Conclusions: Patients undergoing cardiac surgery who are exposed to intraoperative precursor events were
more likely to experience a postoperative MACE. Quality improvement techniques aimed at mitigating the
consequences of precursor events might improve the surgical outcomes for cardiac surgical patients. (J Thorac
Cardiovasc Surg 2014;147:1499-504)An important component of quality improvement in cardiac
surgery is an impartial evaluation of death and major morbid-
ity inpatients undergoingcardiac surgery.Thesemetrics serve
as quality indicators for outcomes, process, and structure of
care.1,2 Specifically, preventable death and morbidity are
logical targets for quality improvement strategies, because
they are potentially avoidable. Unavoidable injury, however,
is thought to occur unexpectedly, with the temporal
sequence of the inciting event to the injury very short. The
published data have suggested that 56% to 87% of deaths
in cardiac patients are nonpreventable,3,4 potentially altering
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The Journal of Thoracic and CarIt is possible that the causal pathway of these ‘‘unavoid-
able’’ injuries begins long before any overt warning signs
are present. Upstream events, such as precursor events,
have received recent attention as a focus for alterability.
Precursor events are events that precede an adverse event
such as death.5 They are undesirable events that can lead
to a subsequent adverse event. Intraoperative precursor
events have been reported to occur in 73.3% of cardiac
cases, with a mean of 3.5 precursor events per case.6
Also, precursor events occurred more frequently in patients
experiencing ‘‘death or near miss.’’ Intraoperative near mis-
ses and major complications have also been associated with
increased postoperative death,7,8 especially if the event
went uncompensated.
Because compensation or appropriate responses to criti-
cal intraoperative events are important to prevent a potential
adverse event from subsequently developing,9 a surgical
team might believe that a precursor event, if compensated
for, would negate this potential. However, it might be,
rather, that these ‘‘forgotten’’ events, whether compensated
for or not, are the nidus in which begins the propagation of
the precursor event toward an adverse event. Usually, such
propagation is prevented through system safeguards10;diovascular Surgery c Volume 147, Number 5 1499
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CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
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Dhowever, failure to recognize the importance of the precur-
sor event could act as a ‘‘hole’’ in this layer of defense. As
such, even nominal events could pose a potential risk to the
patient and could account for death or major injury, regard-
less of the perceived ‘‘preventability.’’
The goal of the present study was to determine whether
intraoperative precursor events, regardless of the compensa-
tion or seriousness, contribute to postoperative death or ma-
jor morbidity. In the present study, we chose to emphasize
the coronary artery bypass grafting (CABG), valve, and
CABG plus valve patient population, because this patient
group encompasses most of current cardiac surgery clinical
practice. Also, we limited the risk profile to low to medium
preoperative predicted risk, because high-risk patients rep-
resent a small proportion of clinical practice, and their acu-
ity might overwhelm any effect precursor events would
have on subsequent outcomes.
METHODS
Data Source
The present studywas a retrospective cohort design. TheMaritimeHeart
Center Cardiac Surgery Registry is a detailed clinical database housed at
the Queen Elizabeth II Health Science Center (Halifax, Nova Scotia,
Canada). It includes pre-, intra-, and postoperative data prospectively col-
lected for all cardiac surgical cases performed at the Queen Elizabeth II
Health Science Center from 1995 to the present. The data are collected
by trained abstractors, and a database administrator maintains the registry.
The database is audited annually.
Study Population
A patient cohort from 2004 to 2009 that included consecutive CABG,
aortic valve replacement, mitral valve repair, and mitral valve replacement
with or without CABG was used to develop a nonparsimonious logistic re-
gression model that described the composite outcome of major adverse car-
diac events (MACE). MACE was defined as in-hospital death, stroke
(permanent or transient), acute renal failure (>176mmol or a 50% increase
from baseline if chronic renal failure), or infection (sepsis, pneumonia, or
deep sternal wound infection). The predictor variables included in the
model were important preoperative variables that might influence the prob-
ability of experiencing postoperative MACE. A detailed description of the
model development can found in the Appendix.
The predicted probability ofMACEwas calculated for each patient in the
model cohort. To define a study cohort of patients with low tomedium risk of
MACE, themodel cohort was truncated at the 75th percentile. Using the pre-
dicted probability of MACE, each patient with postoperative MACE was
matched 1:1 with a patient without postoperativeMACE. A greedy matched
algorithm that proceeded from a 5-digit to a 1-digit match on risk was used.
Precursor Events
Precursor events were defined as undesirable incidents that occurred
proximally in the causal pathway of an adverse event. They are required1500 The Journal of Thoracic and Cardiovascular Surfor the adverse event to occur but do not always result in said event. As
such, precursor events will occur with more frequency than will adverse
events.5 In general, precursor events are easily compensated for by the
care team and are seldom recognized as a critical event in the causal path-
way of an adverse event. Four intraoperative precursor events of interest
were identified through quality assessment exercises at our institution:
(1) bleeding, (2) failure to wean from cardiopulmonary bypass (CPB),
(3) regrafting or repair of conduit or valve, and (4) incomplete revascular-
ization or repair.
Bleeding was defined as any instance of surgical bleeding (other than
related to the grafts) or coagulopathy requiring intervention such as repair,
a return to CPB for repair, administration of blood products, or a delay in
the termination of surgery. Failure to wean fromCPB included any instance
in which the patient did not wean or struggled to wean, requiring a return to
CPB, insertion of an intra-aortic balloon pump, additional inotropic sup-
port, insertion of a ventricular assist device, and pacing or prewean pacing
required to wean in the specific instance of valve surgery. Regrafting or
repair of the conduit or valve included any instance in which regrafting
or repair was undertaken because of issues with conduit length, lie, poor
flow reading, wall motion abnormality on transesophageal echocardio-
gram, bleeding, perivalvular leakage, and persistent stenosis or regurgita-
tion despite repair or replacement. Incomplete revascularization or repair
occurred when not all critically diseased territories had undergone grafting
or persistent stenosis or regurgitation or perivalvular leakage considered
significant by best standard of care practices was not corrected. This could
have been because of an inadequate size of the target vessel, a paucity of
conduit, or other patient or technical factors.
The primary outcome was having 1 intraoperative precursor events.
The operative notes were used to identify the precursor events according
to the surgeons’ description of the events in the operating room (OR). These
operative notes were dictated immediately after the operation before
a MACE occurred, allowing for an unbiased measure of the prevalence
of the precursor events. Patient and surgeon identifiers were removed
from the operative notes for the matched groups, and the anonymous oper-
ative notes were distributed to 5 surgeons for review and identification of
the precursor events. No surgeon received their own operative notes. Any
operative note that reported a death in the OR or that was reported as
a late dictation was removed from the review, along with the matched part-
ner note. Inter-rater reliability was assessed.
A secondary analysis was planned to examine whether the precursor
events were associated with other secondary outcomes, including pump
time, clamp time, intraoperative inotropic use, postoperative blood product
use, low cardiac output syndrome, and ventilator and intensive care unit
length of stay. This was achieved by excluding the MACE events from
the matched groups and then comparing all patients with a precursor event
with those who did not. This was a hypothesis-generating analysis only.Statistical Analysis
Previous research from our institution examining precursor events and
death in a low-risk CABG population revealed that patients who died post-
operatively had had 30%more precursor events than thosewho did not die.
For the study to achieve 80% power with an alpha of 0.05, the required
sample size per group for a 50%, 40%, and 30% relative risk difference
was 48, 112, and 243, respectively. Because the present study had a mixed
population with an unknown risk difference, the largest sample size was
used.
Continuous variables were compared using a 2-tailed t test or Wilcoxon
rank sum test, and categorical variables were analyzed using a chi-square or
Fisher’s exact test, as appropriate. The prevalence of precursor events was
compared between the matched groups (thosewithMACE vs thosewithout
MACE). The outcomes were analyzed using the chi-square test or Fisher’s
exact test, as appropriate.
All statistical analysis was performed using Statistical Analysis Systems
software, version 9.2 (SAS Institute, Cary, NC).gery c May 2014
TABLE 1. Preoperative variables in thematched groups (noMACE vs
MACE)
Variable No MACE (n ¼ 286) MACE (n ¼ 286) P value
Predicted probability 11.9 (0.084-17.90)* 11.9 (0.08-17.98)*
Herman et al Acquired Cardiovascular DiseaseThe institutional review board of the Capital District Health Authority
approved the present study. The requirement to obtain informed consent
was waived under Section 2.1c of the Tri-Council Policy Statement. All
personal identifiers were stripped before data analysis to ensure patient
anonymity and confidentiality.Age (y) 67 (60-74)* 68 (60-75)*
Female gender 23.78 24.48 .845
BMI (kg/m2) .0982
<25 16.78 24.13
25-30 39.51 37.06
30-35 30.07 23.78
>35 13.64 15.03
Diabetes 38.11 38.81 .8635
Hypertension 74.13 77.62 .3284
AF 10.49 11.54 .6887
COPD 17.83 17.83 .9999
CVD 13.99 13.29 .8075
PVD 15.03 15.73 .8167
Frailty 2.8 2.8 .9999
EF<40% 13.99 12.24 .5357
NYHA class .6038
I 26.92 30.07
II 24.13 25.52
III 35.66 30.42
IV 13.29 13.99
Hemoglobin (g/L) .9225
<115 51.05 51.75
115-135 40.21 38.81
>135 8.74 9.44
Creatinine (mg/dL) .9332
<115 75.17 76.22
115-140 15.73 14.69
140-160 3.85 4.55
>160 5.24 4.55
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DRESULTS
Study Population
The model derivation cohort included 4270 consecutive
patients and 17 variables (Table 2). The predicted probabil-
ity of MACE was calculated using the model and assigned
to each patient. To create a low- to medium-risk group, the
cohort was truncated at the 75th percentile of predicted risk
(n ¼ 3192). The mean predicted probability for the entire
cohort and the low- to medium-risk cohort was 10.5 (inter-
quartile range [IQR], 6.1-20.2) and 8 (IQR, 5.4-12), respec-
tively. The low- to medium-risk group experienced 316
MACE events (9.9%).
A total of 311 patients (98.4%) with MACE events were
matched 1:1 (Figure 1). Of these 311 patients, 25 (8%) and
their match were eliminated from the analysis because the
patient had died in the OR (n ¼ 2), the dictation was re-
ported as late (n ¼ 12), or the OR dictation was not found
(n ¼ 9). The preoperative clinical characteristics were sim-
ilar between the matched MACE (n¼ 286) and non-MACE
(n ¼ 286) cases available for analysis (Table 1). The pre-
dicted probability of MACE was almost identical in the
non-MACE (11.9; IQR, 0.084-17.90) and MACE (11.9;
IQR, 0.08-17.98) groups.
Five surgeons reviewed and identified the precursor
events in all cases.FIGURE 1. Histogram of matched major adverse cardiac events (MACE)
cases compared with the total population. The light columns on the upper
and lower axes indicate the total number of cases without (upper axis) and
with (lower axis) MACE. The dark columns indicate the proportion of
matched non-MACE cases (upper axis) to MACE cases (lower axis).
The light blues columns represent all the matched cases.
Redo surgery 9.09 6.29 .2094
Status .5915
Elective 49.3 51.05
In-house 43.36 41.96
Urgent 6.64 5.24
Emergent 0.7 1.75
Procedure type .9403
CABG 57.34 55.94
Valve 13.64 14.34
CABG plus valve 29.02 29.72
Surgeon .6071
A 10.49 14.34
B 11.19 11.54
C 9.79 11.89
D 2.45 2.45
E 9.79 8.04
F 9.79 9.79
G 3.15 3.85
H 19.93 16.08
I 9.09 11.89
J 14.34 10.14
MACE, Major adverse cardiac events; BMI, body mass index; AF, atrial fibrillation;
COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; PVD,
peripheral vascular disease; EF, ejection fraction; NYHA, New York Heart Associa-
tion; CABG, coronary artery bypass grafting. *Interquartile range.
The Journal of Thoracic and Cardiovascular Surgery c Volume 147, Number 5 1501
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DPrimary Outcome
The primary outcome of 1 or more precursor event
occurred significantly more frequently in the MACE group
(33% vs 24%; P ¼ .015; Figure 2).
Each individual precursor event (ie, bleeding, difficulty
weaning, repair or regrafting, and incomplete revasculariza-
tion or repair) was identified in the MACE and non-MACE
groups (Figure 2). The precursor events of bleeding and
difficulty weaning contributed to the outcome the most,
and repair or regrafting and incomplete revascularization
occurred at similar frequencies in both the MACE and the
non-MACE groups.Secondary Analysis
WhenMACEwas excluded, and the patients with precur-
sor events were compared with the patients without precur-
sor events, the pump and clamp time appeared similar and
the intraoperative inotropic use, postoperative blood prod-
uct use, and low cardiac output syndrome appeared to
have greater prevalence. Patients with no precursor events
had a similar prevalence of secondary outcomes as the total
low- to medium-risk population (MACE excluded).DISCUSSION
The objective of the present study was to describe the as-
sociation of intraoperative precursor events and postopera-
tive MACE. We found that cardiac surgery patients who are
exposed to 1 or more intraoperative precursor event are
more likely to experience postoperative MACE (33% vs
24%; P ¼ .015). Individually, the bleeding and difficulty
weaning from CPB precursor events appeared to contribute
the most to the primary outcome.
Although hypothesis-generating only, the results of the
secondary analysis suggested that other important outcomes
(other than MACE) might be higher in patients exposed toFIGURE 2. Frequency of precursor events for major adverse cardiac
events (MACE) and non-MACE groups. The dark bars represent patients
who did not experience a postoperative MACE and the light bars, those
patients who did.
1502 The Journal of Thoracic and Cardiovascular Sura precursor event. Also, patients without precursor events
had a similar prevalence of these events compared with
the entire low- to medium-risk population (excluding
MACE patients), indicating that they were representative
of the entire low- to medium-risk population. Therefore,
precursor events alone could be driving the greater preva-
lence of secondary outcomes in this group.
To understand how precursor events are associated with
the development of an adverse event and how they might
be altered, consideration of the structure of the adverse event
is required. First, one should consider the layers of safe-
guards and system defenses that attempt to prevent adverse
events.11,12 These layers of safeguards act as walls to block
adverse events from occurring or propagating. The layers,
however, are not always intact, with holes that can open or
close and shift around. If the holes align, a direct path
could develop, allowing the adverse event to occur. Next,
one should consider the inciting event as a precursor event,
or an error, preventable or not. These errors can be active
or latent failures.11,13 Active failures are acts committed by
people and could be a mistake or procedural violation that
has immediately visible consequences. Latent failures have
delayed consequences and are generally a result of an
error-provoking environment or a gap in process. These
latent failures can combine with other triggering events,
each penetrating the layers of defense and ‘‘snowballing’’
to the final adverse event.
Active failures are generally compensated for immedi-
ately, and, as such, the surgical teammight believe the event
is no longer an issue. Approximately 90% of all precursor
events have been reported as being adequately compen-
sated6; however, they were still associated with increased
death or near miss. Also, the number of major precursor
events per procedure and the number of precursor events
per surgeon were independent predictors of death or near
miss. This could indicate that compensation alone might
be adequate to prevent downstream adverse events. Surgical
teams might disregard precursor events once they have been
deemed ‘‘compensated for,’’ which starts the propagation
through the system defenses, leading to the adverse event.
Disregarding these events, in itself, might act as an impor-
tant defect in the system defenses. Alternatively, if caused
by a latent failure, the precursor event might overtly be in-
adequately compensated. Intraoperative near misses and
major complications have also been associated with in-
creased postoperative death, especially if the event was un-
compensated in a cardiac population.7,8 As such, both forms
of error or precursor events, regardless of compensation, can
permeate the system defenses and lead to an adverse event.
This lack of a conscious association of precursor events
with subsequent adverse events can further contribute to
the propagation of the event, because increased attention
to these patients is likely required to prevent or limit the
propagation but might not be received by the patients.gery c May 2014
TABLE 2. Nonparsimonious logistic regression forMACE in aCABG/
valve population
Variable Odds ratio 95% CI
Age square 1.0 1.0-1.03
Female gender 0.8 0.6-1.0
PVD 1.6 1.2-1.9
Frailty 1.7 1.2-2.5
BMI (kg/m2)
25-30 1.0 —
<25 1.2 0.9-1.5
30-35 1.2 0.9-1.5
>35 1.5 1.1-2.1
NYHA class
I 1.0 —
II 1.3 1.0-1.6
III 1.2 0.9-1.5
IV 1.3 1.0-1.8
Hemoglobin
<115 (elective) 1.2 0.7-2.2
115-135 (elective) 1.1 0.9-1.6
>135 (elective) 1.0 —
<115 (in-house) 1.8 1.3-2.6
115-135 (in-house) 1.4 0.9-1.9
>135 (in-house) 1.0 —
<115 (urgent) 2.9 1.5-2.5
115-135 (urgent) 1.4 0.7-2.7
>135 (urgent) 1.0 —
<115 (emergent) 1.6 0.6-4.0
115-135 (emergent) 1.3 0.5-3.2
>135 (emergent) 1.0 —
Creatinine (mg/dL)
<115 1.0 —
115-140 1.3 1.1-1.7
140-160 1.6 1.1-2.2
>160 1.6 1.2-2.2
Preoperative AF 1.4 1.1-1.8
Diabetes 1.5 1.1-1.8
EF<40% 1.3 1.0-1.7
COPD 1.2 0.9-1.5
CVD 1.2 1.0-1.6
Hypertension 1.1 0.9-1.5
Preoperative RF 1.3 0.9-1.9
Procedure
CABG 1.0 —
Valve 1.2 0.9-1.5
CABG plus valve 2.3 1.8-3.0
Status
In-house 1.1 0.9-1.5
Urgent 1.8 1.8-3.6
Emergent 4.3 2.9-7.4
Redo surgery 1.4 0.9-1.9
Surgeon
A 1.0 —
B 1.1 0.7-1.6
C 1.1 0.7-1.6
D 1.1 0.6-2.2
E 1.2 0.8-1.7
(Continued)
TABLE 2. Continued
Variable Odds ratio 95% CI
F 0.7 0.5-1.1
G 1.1 0.6-1.9
H 1.1 0.8-1.5
I 0.8 0.5-1.1
J 1.1 0.8-1.6
The nested interaction of hemoglobin and status shows the effect of hemoglobin at
each level of status. CI, Confidence interval; RF, renal failure;MACE, Major adverse
cardiac events; BMI, body mass index; AF, atrial fibrillation; COPD, chronic obstruc-
tive pulmonary disease; CVD, cardiovascular disease; PVD, peripheral vascular dis-
ease; EF, ejection fraction; NYHA, New York Heart Association; CABG, coronary
artery bypass grafting.
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with postoperative events, however, will not, on its own, im-
prove the outcomes for our patients. Because the precursor
events are not necessarily preventable, more active efforts
are required, after the precursor event, to prevent the post-
operative adverse events. Efforts should include quality
improvement initiatives designed to increase or improve
the system defenses so that they are an impenetrable wall,
preventing the precursor event from propagating toward
the adverse event.
Our study had a few limitations. First, the low- to
medium-risk cohort was selected by truncating the popula-
tion at the 75th percentile of the predicted risk for postoper-
ative MACE. It might be that as the risk of the patient
increases, the effect of a precursor event is less impactful be-
cause of the various other risk factors and, consequently, the
effect of the precursor events on the occurrence of MACE is
blunted. Second, the only measure of time delay of dictation
(which would produce a less detailed and more biased oper-
ative note) was the surgeon report in the dictation. No other
attempt, for practical reasons, was made to validate the time
to dictation. As such, late dictations, which would be less
likely to report a precursor event, might have been included
in the analysis. Assuming that this was a random occur-
rence, both groups should have been biased equally. Also,
the selection of the 4 precursor events was from quality as-
sessment work at our institution and represented events be-
lieved common and potentially important at our institution.
It could be that we did not include other potentially impor-
tant events. Some precursor events might behave differently
for different procedures. For example, the incidence of re-
grafting or repair and incomplete revascularization or repair
was not different between the 2 groups compared with the
mixed population. It might be that this event is more rele-
vant when compared within a single procedure group.
Our study results have demonstrated that precursor
events are common and that they affect postoperative ad-
verse events. As the importance of even nominal precursor
events becomes clear, efforts aimed at either preventing
these events or mitigating their consequences will be essen-
tial to decreasing postoperative adverse events. Becausediovascular Surgery c Volume 147, Number 5 1503
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Dquality improvement is a cornerstone of cardiac surgery,
these types of initiatives are vital in closing the quality im-
provement loop and providing continued improved out-
comes for our patients.
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APPENDIX
Model Development
Variable selection. The candidate variables for model
development included the following preoperative character-
istics: age, gender, diabetes, frailty, chronic obstructive pul-
monary disease, redo sternotomy, atrial fibrillation,
hemoglobin, peripheral vascular disease, cerebrovascular
disease, creatinine, ejection fraction <40%, New York
Heart Association classification (I-IV), and body mass in-
dex. Surgery-related data, such as the urgency of surgery
and procedure type, were also included. These candidate1504 The Journal of Thoracic and Cardiovascular Survariables were chosen a priori and selected through a rigor-
ous review of the published data.1-9,13-15
The multicollinearity of the candidate variables was as-
sessed using the variance inflation factor. The linear rela-
tionships of the natural variables and their transformations
were assessed through locally weighted scatter plot smooth-
ing (LOESS) regression.16 The World Health Organization
classification of body mass index was used.Model Evaluation
Nonparsimonious multivariate logistic regression analy-
sis was used to describe MACE.
Age, gender, procedure type, and surgical priority were
chosen a priori and forced into the model. Stepwise selec-
tion was implemented for the remainder of the candidate
variables. The concordance statistic and 2 log likelihood
were evaluated to assess the contribution of each variable
to the model. If a variable did not contribute to an increase
in the C or 2 log likelihood statistic, it was not retained in
the model.
Model discrimination was determined using the concor-
dance statistic.17 Model calibration was assessed using the
Hosmer-Lemeshow goodness-of-fit statistic18,19 and
calibration plots.20 Deciles of observed and predicted prob-
abilities of MACE were plotted for the calibration plots.5
The bootstrap procedure was used to internally validate
the model.Model Performance
A nonparsimonious multivariate logistic regression anal-
ysis was used to describe MACE.
Assessment of the variance inflation for each variable
revealed that no variable exceeded 1.5, allowing all the vari-
ables to remain in the final model.
By LOESS regression, the squared transformation of the
continuous variable age had the most linear relationship
with the log odds of the outcome. Hemoglobin and creati-
nine had nonlinear relationships with the outcome, despite
transformation. The inflection points of the natural variable
were taken to create the categorical variables. The hemoglo-
bin inflection points were 115 and 135 and for creatinine
were 115, 140, and 160.
A total of 18 variables remained in the logistic regression
model, including a nested interaction of hemoglobin and
status. The significant predictors of MACE included vari-
ables such as frailty, body mass index>35 kg/m2, all creat-
inine levels, diabetes mellitus, emergent and urgent status,
and CABG plus valve procedure type.
The concordance statistic for the logistic regression was
0.77, equivalent to a receiver operating characteristic of
77% (95% confidence interval, 76-80). The Hosmer-
Lemeshow goodness of fit statistic was 0.1218.gery c May 2014
